Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Berger

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
BMC Medical Research Methodology|June 30, 2023
Use of electronic health data to identify patients with moderate-to-severe osteoarthritis of the hip and/or knee and inadequate response to pain medicationsYi Lu, Michael L Ganz, Rebecca L Robinson, et al.
BMC Pulmonary Medicine|July 6, 2026
Factors associated with delayed diagnosis of fibrotic interstitial lung disease: a retrospective cohort studyHyun J Kim, Surbhi Shah, Sharashchandra Shetty, et al.
Future Oncology (London, England)|May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myelomaDaanish Hoda, Robert Richards, Edward A Faber, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
BMC Medical Research Methodology|June 30, 2023
Use of electronic health data to identify patients with moderate-to-severe osteoarthritis of the hip and/or knee and inadequate response to pain medicationsYi Lu, Michael L Ganz, Rebecca L Robinson, et al.
BMC Pulmonary Medicine|July 6, 2026
Factors associated with delayed diagnosis of fibrotic interstitial lung disease: a retrospective cohort studyHyun J Kim, Surbhi Shah, Sharashchandra Shetty, et al.
Future Oncology (London, England)|May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myelomaDaanish Hoda, Robert Richards, Edward A Faber, et al.
Pageof 7